Sitemap

EU Commission Concludes Exploratory Talks With Valneva To Secure A New Potential Vaccine

More...

WHO Describes Immunisation Process In Serbia As Impressive

Prime Minister Ana Brnabic talked with World...

Humanitarian Cash Transfers For Families With Children As Part Of The COVID-19 Recovery Response

Darija Kisic Tepavcevic, Minister of Labour, Employment,...

Committee On Constitutional Affairs Adopts Bill To Change Constitution

Prime Minister Ana Brnabic attended the 30th session...

Production Of Sputnik V Launched In Serbia

The Russian Direct Investment Fund (RDIF, Russia’s...

WHO Describes Immunisation Process In Serbia As Impressive

Prime Minister Ana Brnabic talked with World Health Organisation (WHO) Regional Director for Europe Hans Kluge about the epidemiological...

Humanitarian Cash Transfers For Families With Children As Part Of The COVID-19 Recovery Response

Darija Kisic Tepavcevic, Minister of Labour, Employment, Veteran and Social Affairs, Anthony Godfrey, US Ambassador to the Republic of...

Committee On Constitutional Affairs Adopts Bill To Change Constitution

Prime Minister Ana Brnabic attended the 30th session of the Committee on Constitutional Affairs and Legislation of the Serbian parliament,...

Production Of Sputnik V Launched In Serbia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Institute of Virology, Vaccines and Sera “Torlak” announce...

Start Of The New EU For Local Development Programme – EU PRO Plus

EU PRO Plus, a new European Union programme for local development, which aims to contribute to the overall social...

European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19.

The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses.

Today’s finalisation of exploratory talks with Valneva come in addition to an already secured broad portfolio of vaccines to be produced in Europe, including the contracts already signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, and Moderna and exploratory talks concluded with Novavax. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective, as is already the case for BioNTech/Pfizer and Moderna, recently authorised in the EU. Member States are able to donate vaccines to lower and middle-income countries or to re-direct it to other European countries.

President of the European Commission, Ursula von der Leyen, said: “The continuing COVID-19 pandemic in Europe and around the globe makes it more important than ever that all Member States have access to the broadest possible portfolio of vaccines to help protect people in Europe and beyond. Today’s step toward reaching an agreement with Valneva further complements the EU’s vaccines portfolio and demonstrates the Commission’s commitment to find a lasting solution to the pandemic.”

Stella Kyriakides, Commissioner for Health and Food Safety, said: With this eighth vaccine, we are adding to our already broad and diversified range of vaccines in our portfolio. By doing this, we can maximise our chances of making sure that all citizens can have access to safe and effective of vaccinations by the end of 2021. All Member States have now started their vaccination campaigns and will start receiving an increasing number of doses in order to cover all their needs during this year.”

Valneva is a European biotechnology company developing an inactivated virus vaccine. This is a traditional vaccine technology, used for 60-70 years, with established methods and a high level of safety. Most of the influenza vaccines and many childhood vaccines use this technology. This is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe.

The Commission, with the support of EU Member States, has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company’s experience in vaccine development and its production capacity to supply all EU Member States.

Related Articles

The First Conference On The Air Protection Programme In Serbia

The first conference on preparing the Draft of the Air Protection Programme in the Republic of Serbia with accompanying Action plan was held. The programme is...

Production Of Sputnik V Launched In Serbia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Institute of Virology, Vaccines and Sera “Torlak” announce the launch of production of...

Distribution Of Laptops And Tablets, Bridging Digital Divide In Serbia For The Most Vulnerable Children Project

The Head of the European Union Delegation to Serbia, Ambassador Sem Fabrizi, UNICEF Representative in Serbia, Deyana Kostadinova, and Ivica Rakovic, State Secretary in...

Vaccine Passports Are Sreading Across The World Here’s How They Could Work In The US

Vaccine passports are set to become a part of everyday life right across the world as governments race to vaccinate their populations against the...

Skopje Launches Mass Coronavirus Vaccination With Russia’s Sputnik V

Vaccines are available for police officers, Interior Ministry employees, pharmacists, pre-school and school teachers as well as other categories qualified as a critical group Mass...

Serbian Torlak Institute To Get Technology For Sputnik V Vaccine

Serbia’s Torlak Institute on Monday signed a technology transfer agreement with the Russian Direct Investment Fund and the Russian pharmaceuticals company Generium under which...

Healthy Nature For A Healthy Life, The New Message From The Serbian Buses

The project “EU for Natura 2000 in Serbia” is launching today the campaign “Healthy nature for a healthy life” with the aim to increase...

Coronavirus: What Are The Lockdown Rules In Different EU Countries?

Cases of COVID-19 are rising in many parts of the European Union. Consequently, some governments have decided to shut down many areas of public...